NEW YORK, Feb. 14, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Read the full report: https://www.reportlinker.com/p03646062/?utm_source=PRN

Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Commercial Biotechnology Separation Systems estimated at US$24.6 Billion in the year 2022, is projected to reach a revised size of US$31 Billion by 2030, growing at aCAGR of 2.9% over the period 2022-2030. Conventional, one of the segments analyzed in the report, is projected to record 2.7% CAGR and reach US$19 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Modern segment is readjusted to a revised 3.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 4.8% CAGR

The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 2.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.

Select Competitors (Total 46 Featured)

- 3M Company

- AB Sciex

- Agilent Technologies, Inc.

- Alfa Laval AB

- Alfa Wassermann Separation Technologies LLC

- Beckman Coulter Inc.

- Becton Dickinson and Company

- Bio-Rad Laboratories Inc.

- Flottweg SE

- Fluidigm Corporation

- GE Healthcare

- Hitachi High-Technologies Corp.

- Illumina Inc.

- Merck KGaA

- Pall Corporation

- PerkinElmer Inc.

- ProMetic Life Sciences Inc.

- Repligen Corporation

- Sartorius Stedim Biotech SA

- Shimadzu Scientific Instruments

- Sysmex Partec GmbH

- Thermo Fischer Scientific Inc.

Read the full report: https://www.reportlinker.com/p03646062/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

Separation Technologies Drive Biotechnology Industry

Recent Market Activity

Developed Markets Lead the Way while Emerging Markets Promise

Growth

DNA Microarrays - Largest & Fastest Growing Segment

Liquid Chromatography - One of the Leading Biotechnology

Separation Technologies

Factors Sustaining Market Growth

Factors Restraining Growth

Commercial Biotechnology Separation Systems - Global Key

Competitors Percentage Market Share in 2022 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for

Players Worldwide in 2022 (E)

Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3M (USA)

AB Sciex LLC (USA)

Agilent Technologies, Inc. (USA)

Alfa Laval AB (Sweden)

Alfa Wassermann Separation Technologies, LLC (USA)

Beckman Coulter, Inc. (USA)

Becton, Dickinson and Company (USA)

Bio-Rad Laboratories, Inc. (USA)

Flottweg SE (Germany)

Fluidigm Corporation (USA)

GE Healthcare (USA)

Groupe Novasep (France)

Hitachi High-Technologies Corp. (Japan)

Illumina, Inc. (USA)

Merck KGaA (Germany)

Pall Corporation (USA)

PerkinElmer, Inc. (USA)

ProMetic Life Sciences, Inc. (Canada)

Repligen Corporation (USA)

Sartorius Stedim Biotech SA (France)

SEPMAG (Spain)

Shimadzu Scientific Instruments (USA)

Sysmex Partec GmbH (Germany)

Thermo Fisher Scientific, Inc. (USA)

3. MARKET TRENDS & DRIVERS

Bioseparation Systems - Invaluable Tools in Biopharmaceutical

Manufacturing

A Peek into Biopharmaceutical Manufacturing

Downstream Processing of Biosynthetic Products - An Overview

Surging Biopharmaceutical Market Spurs Demand for Bioseparation

Systems

New Biologic License Application (BLA) Approvals: 2017

New Biologic License Application (BLA) Approvals: 2016

New Biologic License Application (BLA) Approval: 2015

Evolving Biopharmaceutical Industry Emphasizes on Novel

Technologies

Increasing Emphasis on Personalized Medicine Drives Market Growth

Rise in Healthcare Spending Bodes Well for Market Growth

Aging Population Drives Biotechnology Separation Systems Market

Global Aging Population Statistics - Opportunity Indicators

Increasing Incidence of Cancer Drives Biotechnology Separation

Systems Market

Increasing Competition Spurs Renewed Focus on Efficiencies

Growing Orphan Drugs Market Draws Attention towards

Manufacturing Flexibility

Downstream Processing - A Major Trend among Biopharmaceutical

Manufacturers

Upstream and Downstream Mismatch Turns Focus towards Innovative

Technologies

Protein Separation in Biopharmaceutical Space Assumes Greater

Significance

Growing Market for Monoclonal Antibodies - A Key Review of

Current Status and Future Prospects

Approved Monoclonal Antibodies: 2014-2017

An Insight into Bioseparation of mAbs

Market Potential for Biosimilars - A Case for Substantial

Demand for Separation Technologies

US Approved Biosimilars as of December 2017

Europe Approved Biosimilars as of December 2017

Patent Expiries Create Opportunities for Biosimilar Manufacturers

Patent Expiries of Major Biologics in the US and Europe

Huge Biopharmaceutical Pipeline - A Clear Indicator of Future

Prospects

Disposables to Infuse Cost Effectiveness in Biopharmaceutical

Production

Single-Use Products Gain Significant Attention

Market Prospects for Single-Use Disposable Technologies

Select Commercial Disposable/Single-Use Technologies by Process

Technique

Innovations in Single-use Systems

Modular Bioprocessing - An Emerging Trend

Leachables and Extractables Trounce Enthusiasm around Disposables

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2022 through 2030 and

% CAGR

Table 2: World Historic Review for Commercial Biotechnology

Separation Systems by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2012 through 2021 and % CAGR

Table 3: World 18-Year Perspective for Commercial Biotechnology

Separation Systems by Geographic Region - Percentage Breakdown

of Value Sales for USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets for

Years 2012, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for

Conventional by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Conventional by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 6: World 18-Year Perspective for Conventional by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for

Modern by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Modern by Geographic Region -

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 9: World 18-Year Perspective for Modern by Geographic

Region - Percentage Breakdown of Value Sales for USA, Canada,

Japan, China, Europe, Asia-Pacific, Latin America, Middle East

and Africa for Years 2012, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for

Pharmaceutical by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Pharmaceutical by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 12: World 18-Year Perspective for Pharmaceutical by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for Food &

Cosmetics by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Food & Cosmetics by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 15: World 18-Year Perspective for Food & Cosmetics by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for

Agriculture by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Agriculture by Geographic

Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin

America, Middle East and Africa Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 18: World 18-Year Perspective for Agriculture by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for

Other End-Uses by Geographic Region - USA, Canada, Japan,

China, Europe, Asia-Pacific, Latin America, Middle East and

Africa Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Other End-Uses by

Geographic Region - USA, Canada, Japan, China, Europe,

Asia-Pacific, Latin America, Middle East and Africa Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 21: World 18-Year Perspective for Other End-Uses by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa for Years 2012, 2023 & 2030

Table 22: World Commercial Biotechnology Separation Systems

Market Analysis of Annual Sales in US$ Million for Years 2012

through 2030

III. MARKET ANALYSIS

UNITED STATES

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in the United

States for 2023 (E)

Table 23: USA Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 24: USA Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 25: USA 18-Year Perspective for Commercial Biotechnology

Separation Systems by Method - Percentage Breakdown of Value

Sales for Conventional and Modern for the Years 2012, 2023 &

2030

Table 26: USA Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 27: USA Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 28: USA 18-Year Perspective for Commercial Biotechnology

Separation Systems by End-Use - Percentage Breakdown of Value

Sales for Pharmaceutical, Food & Cosmetics, Agriculture and

Other End-Uses for the Years 2012, 2023 & 2030

CANADA

Table 29: Canada Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 30: Canada Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 31: Canada 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 32: Canada Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 33: Canada Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 34: Canada 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

JAPAN

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in Japan for

2023 (E)

Table 35: Japan Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 36: Japan Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 37: Japan 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 38: Japan Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 39: Japan Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 40: Japan 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

CHINA

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in China for

2023 (E)

Table 41: China Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 42: China Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 43: China 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 44: China Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 45: China Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 46: China 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

EUROPE

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in Europe for

2023 (E)

Table 47: Europe Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Geographic

Region - France, Germany, Italy, UK, Spain, Russia and Rest of

Europe Markets - Independent Analysis of Annual Sales in US$

Million for Years 2022 through 2030 and % CAGR

Table 48: Europe Historic Review for Commercial Biotechnology

Separation Systems by Geographic Region - France, Germany,

Italy, UK, Spain, Russia and Rest of Europe Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 49: Europe 18-Year Perspective for Commercial

Biotechnology Separation Systems by Geographic Region -

Percentage Breakdown of Value Sales for France, Germany, Italy,

UK, Spain, Russia and Rest of Europe Markets for Years 2012,

2023 & 2030

Table 50: Europe Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 51: Europe Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 52: Europe 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 53: Europe Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 54: Europe Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 55: Europe 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

FRANCE

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in France for

2023 (E)

Table 56: France Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 57: France Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 58: France 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 59: France Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 60: France Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 61: France 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

GERMANY

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in Germany for

2023 (E)

Table 62: Germany Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 63: Germany Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 64: Germany 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 65: Germany Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 66: Germany Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 67: Germany 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

ITALY

Table 68: Italy Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: Italy Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 70: Italy 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 71: Italy Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 72: Italy Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 73: Italy 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

UNITED KINGDOM

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in the United

Kingdom for 2023 (E)

Table 74: UK Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 75: UK Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 76: UK 18-Year Perspective for Commercial Biotechnology

Separation Systems by Method - Percentage Breakdown of Value

Sales for Conventional and Modern for the Years 2012, 2023 &

2030

Table 77: UK Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 78: UK Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 79: UK 18-Year Perspective for Commercial Biotechnology

Separation Systems by End-Use - Percentage Breakdown of Value

Sales for Pharmaceutical, Food & Cosmetics, Agriculture and

Other End-Uses for the Years 2012, 2023 & 2030

SPAIN

Table 80: Spain Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 81: Spain Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 82: Spain 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 83: Spain Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 84: Spain Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 85: Spain 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

RUSSIA

Table 86: Russia Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 87: Russia Historic Review for Commercial Biotechnology

Separation Systems by Method - Conventional and Modern Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 88: Russia 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 89: Russia Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 90: Russia Historic Review for Commercial Biotechnology

Separation Systems by End-Use - Pharmaceutical, Food &

Cosmetics, Agriculture and Other End-Uses Markets - Independent

Analysis of Annual Sales in US$ Million for Years 2012 through

2021 and % CAGR

Table 91: Russia 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

REST OF EUROPE

Table 92: Rest of Europe Recent Past, Current & Future Analysis

for Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 93: Rest of Europe Historic Review for Commercial

Biotechnology Separation Systems by Method - Conventional and

Modern Markets - Independent Analysis of Annual Sales in US$

Million for Years 2012 through 2021 and % CAGR

Table 94: Rest of Europe 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 95: Rest of Europe Recent Past, Current & Future Analysis

for Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 96: Rest of Europe Historic Review for Commercial

Biotechnology Separation Systems by End-Use - Pharmaceutical,

Food & Cosmetics, Agriculture and Other End-Uses Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 97: Rest of Europe 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

ASIA-PACIFIC

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific

for 2023 (E)

Table 98: Asia-Pacific Recent Past, Current & Future Analysis

for Commercial Biotechnology Separation Systems by Geographic

Region - Australia, India, South Korea and Rest of Asia-Pacific

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2022 through 2030 and % CAGR

Table 99: Asia-Pacific Historic Review for Commercial

Biotechnology Separation Systems by Geographic Region -

Australia, India, South Korea and Rest of Asia-Pacific Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 100: Asia-Pacific 18-Year Perspective for Commercial

Biotechnology Separation Systems by Geographic Region -

Percentage Breakdown of Value Sales for Australia, India, South

Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 &

2030

Table 101: Asia-Pacific Recent Past, Current & Future Analysis

for Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 102: Asia-Pacific Historic Review for Commercial

Biotechnology Separation Systems by Method - Conventional and

Modern Markets - Independent Analysis of Annual Sales in US$

Million for Years 2012 through 2021 and % CAGR

Table 103: Asia-Pacific 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 104: Asia-Pacific Recent Past, Current & Future Analysis

for Commercial Biotechnology Separation Systems by End-Use -

Pharmaceutical, Food & Cosmetics, Agriculture and Other

End-Uses - Independent Analysis of Annual Sales in US$ Million

for the Years 2022 through 2030 and % CAGR

Table 105: Asia-Pacific Historic Review for Commercial

Biotechnology Separation Systems by End-Use - Pharmaceutical,

Food & Cosmetics, Agriculture and Other End-Uses Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

Table 106: Asia-Pacific 18-Year Perspective for Commercial

Biotechnology Separation Systems by End-Use - Percentage

Breakdown of Value Sales for Pharmaceutical, Food & Cosmetics,

Agriculture and Other End-Uses for the Years 2012, 2023 & 2030

AUSTRALIA

Commercial Biotechnology Separation Systems Market Presence -

Strong/Active/Niche/Trivial - Key Competitors in Australia for

2023 (E)

Table 107: Australia Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by Method -

Conventional and Modern - Independent Analysis of Annual Sales

in US$ Million for the Years 2022 through 2030 and % CAGR

Table 108: Australia Historic Review for Commercial

Biotechnology Separation Systems by Method - Conventional and

Modern Markets - Independent Analysis of Annual Sales in US$

Million for Years 2012 through 2021 and % CAGR

Table 109: Australia 18-Year Perspective for Commercial

Biotechnology Separation Systems by Method - Percentage

Breakdown of Value Sales for Conventional and Modern for the

Years 2012, 2023 & 2030

Table 110: Australia Recent Past, Current & Future Analysis for

Commercial Biotechnology Separation Systems by End-Use -

Please contact our Customer Support Center to get the complete Table of Contents

Read the full report: https://www.reportlinker.com/p03646062/?utm_source=PRN

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

View original content to download multimedia:https://www.prnewswire.com/news-releases/global-commercial-biotechnology-separation-systems-market-to-reach-31-billion-by-2030-301745479.html

SOURCE Reportlinker